This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_OROPHARYNG_EXALLC for full statistics.
Malignant neoplasm of oropharyng
C3_OROPHARYNG
oropharynx cancer: A primary or metastatic malignant neoplasm that affects the oropharynx.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
51 |
4. Check minimum number of eventsNone |
51 |
5. Include endpointsNone |
51 |
6. Filter based on genotype QC (FinnGen only) |
51 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of oropharyng
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of oropharynx, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of oropharynx
- Malignant neoplasm of oropharynx, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of head and neck
- Malignant neoplasm of head and neck, excluding all cancers (controls excluding all cancers)
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 51 | 14 | 37 |
| Unadjusted period prevalence (%) | 0.01 | 0.00 | 0.02 |
| Median age at first event (years) | 67.50 | 65.96 | 68.08 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 50
- Matched controls
- 502
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
JDB10
NOMESCO Finland
Percutaneous gastrostomy
259.6
33.4
31
*
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
179.7
31.2
30
*
130
Kela drug reimbursment
Malignant tumour
42.7
27.5
38
34
R4190
NOMESCO Finland
Nutritional therapy
68.7
22.6
25
7
8070/3-C10.9
ICD-O-3
Squamous cell carcinoma, NOS, of oropharynx, NOS
+∞
21.4
19
*
C10.3
ICD-10 Finland
Malignant neoplasm: Posterior wall of oropharynx
+∞
18.9
17
*
N02AA05
ATC
oxycodone; systemic
19.4
18.7
33
45
WF002
NOMESCO Finland
Radical radiotherapy
26.4
18.7
27
21
A03FA01
ATC
metoclopramide; systemic, rectal
15.7
16.9
34
59
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
59.3
16.9
19
5
UJC01
NOMESCO Finland
Scopy of lower throat
208.5
15.4
15
*
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
+∞
14.2
13
*
YA1CD
NOMESCO Finland
Very extensive CT examination of head and neck for dose design of radiotherapy
+∞
14.2
13
*
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
85.6
12.3
13
*
A04AA01
ATC
ondansetron; systemic, rectal
16.8
11.2
18
16
C10.0
ICD-10 Finland
Malignant neoplasm: Vallecula
+∞
10.8
10
*
GBB00
NOMESCO Finland
Tracheostomy
51.3
10.5
12
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
20.7
10.3
15
10
C10.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of oropharynx
+∞
9.7
9
*
SAA03
NOMESCO Finland
Extended examination of mouth
6.9
9.4
34
117
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
12.2
9.3
17
20
ENA10
NOMESCO Finland
Biopsy of pharynx
+∞
8.6
8
*
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
+∞
8.6
8
*
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
17.0
8.4
13
10
EBA15
NOMESCO Finland
Extraction of large number of teeth
14.4
8.4
14
13
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
6.0
8.2
31
107
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
11.7
7.7
14
16
C01
ICD-10 Finland
Malignant neoplasm of base of tongue
93.4
7.6
8
*
H02AB02
ATC
dexamethasone; systemic
8.3
7.5
17
29
GDA98
NOMESCO Finland
Other bronchoscopic incision, excision of lesion or repair of lung
+∞
7.5
7
*
D10.9
ICD-10 Finland
Benign neoplasm: Pharynx, unspecified
+∞
7.5
7
*
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
+∞
7.5
7
*
C10.2
ICD-10 Finland
Malignant neoplasm: Lateral wall of oropharynx
+∞
7.5
7
*
A06AD11
ATC
lactulose; oral
8.0
7.3
17
30
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
8.5
7.2
16
26
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
9.2
7.2
15
22
A02BC05
ATC
esomeprazole; systemic
5.0
6.8
34
149
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
8.8
6.6
14
21
PJD71
NOMESCO Finland
Extended sparing excision of cervical lymph nodes
79.6
6.6
7
*
EP1DG
NOMESCO Finland
Very extensive examination of soft tissue of neck with high intesity magnet
31.0
6.4
8
*
8070/3-C10.3
ICD-O-3
Squamous cell carcinoma, NOS, of posterior wall of oropharynx
+∞
6.4
6
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
17.9
6.2
9
6
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(4035726)
23
39
9.92
14.55
1.4
1.4
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
30
69
9.13
14.55
9.1
3.5
mmol/l
0.7
0.8
2.51
30
64
(40768804) Tissue Pathology biopsy report
36
168
4.89
6.65
2.4
2.0
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
26
108
3.87
5.35
5.0
3.6
%
93.5
88.5
0.50
26
108
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
22
85
3.79
4.97
2.5
2.2
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
27
124
3.50
4.63
3.0
2.3
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
33
174
3.54
4.51
4.6
3.9
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
28
143
3.12
3.86
9.4
4.1
mmol/l
2.4
2.3
0.65
28
125
(3035637) Corticotropin [Mass/volume] in Plasma
6
5
13.33
3.86
1.3
1.8
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
11
35
3.73
3.14
1.3
1.2
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
15
59
3.19
3.13
1.8
1.6
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
14
55
3.13
2.91
2.1
1.9
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
37
246
2.84
2.81
16.5
11.7
e9/l
4.6
4.3
0.32
32
209
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
5
6
9.06
2.81
1.2
1.3
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
23
125
2.53
2.59
4.3
4.8
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
17
80
2.69
2.54
5.4
3.1
mmol/l
2.5
2.4
1.47
17
67
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
35
239
2.48
2.32
11.7
7.1
umol/l
9.5
12.1
1.50
35
226
(40758558) Short blood count panel - Blood
21
115
2.40
2.28
15.0
8.4
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
14
63
2.68
2.26
2.9
2.0
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
6
14
4.70
2.22
1.5
1.2
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
8
26
3.45
2.12
11.4
7.7
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
23
136
2.26
2.06
3.8
3.4
u/l
32.9
31.3
0.12
23
129
(3014007) Fractional oxyhemoglobin in Arterial blood
9
34
2.99
1.98
13.8
9.5
%
94.9
94.3
—
9
34
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
8
167
0.38
1.95
4.1
4.3
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
18
98
2.29
1.93
1.3
1.3
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
13
62
2.47
1.85
6.2
4.9
mmol/l
1.0
1.0
0.21
13
57
(42870588) Differential panel, method unspecified - Blood
23
142
2.13
1.81
5.7
5.4
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
9
38
2.66
1.55
1.2
1.5
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
27
187
1.94
1.48
8.2
6.4
mmol/l
1.2
1.2
0.68
27
167
(40761536) Microorganisms panel - Urine sediment
0
41
0.00
1.38
0.0
3.2
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
28
201
1.87
1.34
10.8
6.8
mmol/l
1.2
1.2
0.43
28
171
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
5
18
2.96
1.31
1.8
2.8
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
13
73
2.05
1.25
2.5
2.5
e6/l
0.3
2.3
—
7
40
(3022621) pH of Urine by Test strip
0
34
0.00
1.21
0.0
2.3
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
33
256
1.82
1.17
8.7
5.0
mmol/l
7.1
6.9
0.25
33
240
(3000991) Gas panel - Venous blood
8
41
2.12
1.15
14.8
7.6
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
21
282
0.57
1.13
3.5
4.1
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
6
118
0.44
1.12
1.8
1.7
mmol/l
1.4
1.3
—
6
97
(3013512) EKG study
8
137
0.51
1.03
5.8
3.9
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
42
459
0.52
1.01
17.3
11.1
u/l
26.9
25.7
0.16
42
440
(3002256) Pathology report gross observation
10
55
2.02
1.00
1.1
1.2
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
27
205
1.67
0.97
6.6
6.7
e9/l
0.6
0.6
0.16
20
174
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
13
80
1.84
0.96
2.2
1.9
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
27
207
1.65
0.92
6.6
6.7
e9/l
0.0
0.0
0.29
20
175
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
13
81
1.81
0.92
2.5
2.3
e6/l
1.0
1.3
—
7
47
(3019198) Lymphocytes [#/volume] in Blood
27
210
1.61
0.85
6.6
6.8
e9/l
1.5
1.7
0.56
19
185
(3013115) Eosinophils [#/volume] in Blood
27
212
1.58
0.81
6.6
6.9
e9/l
0.2
0.2
0.27
19
184
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
10
60
1.83
0.79
2.5
1.6
—
—
—
0
0
(3003338) MCHC [Mass/volume]
39
336
1.68
0.77
34.4
22.3
g/l
329.7
332.4
0.91
39
336
(3019060) Gas panel - Arterial blood
7
40
1.87
0.75
5.0
4.3
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
5
25
2.11
0.75
2.2
1.3
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
42
452
0.60
0.75
34.5
18.5
umol/l
71.2
82.5
2.56
42
452
(3002179) Metamyelocytes/100 leukocytes in Blood
5
27
1.94
0.70
5.0
4.3
—
0.9
—
0
7
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
10
63
1.73
0.68
2.5
1.7
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
5
86
0.54
0.63
1.0
1.8
pmol/l
735.6
433.3
—
5
75
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
15
198
0.66
0.62
1.8
4.8
%
20.2
21.4
—
5
100
(3031040) Bacteria [#/volume] in Urine by Automated count
23
278
0.69
0.59
3.3
4.4
—
24.9
—
0
7
(40761511) CBC panel - Blood by Automated count
41
444
0.61
0.57
19.5
14.1
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
39
346
1.54
0.57
14.2
8.1
u/l
79.5
79.4
0.01
39
324
(3009542) Hematocrit [Volume Fraction] of Blood
41
372
1.52
0.49
32.5
16.0
%
37.7
40.4
2.28
33
247
(1761868) Lipid panel - Serum or Plasma
11
147
0.68
0.46
2.7
2.8
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
5
32
1.62
0.43
19.0
6.8
mmol/l
29.4
24.8
—
5
32
(3017181) Myelocytes/100 leukocytes in Blood
5
33
1.57
0.42
5.4
4.3
—
1.3
—
0
13
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
0
15
0.00
0.42
0.0
1.0
—
0.0
—
0
15
(3045414) Leukocytes [Presence] in Urine
0
16
0.00
0.42
0.0
1.4
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
0
16
0.00
0.42
0.0
4.4
—
—
—
0
0
(3015736) pH of Urine
12
154
0.71
0.39
3.0
4.1
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
5
78
0.60
0.39
1.2
1.2
—
0.8
—
0
19
(3026008) Bacteria identified in Urine by Culture
10
129
0.72
0.33
2.5
3.0
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
14
166
0.78
0.25
3.9
3.3
e6/l
2.6
39.1
—
8
126
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
5
40
1.28
0.23
2.0
2.7
ug/l
3.6
8.4
—
5
35
(3027315) Oxygen [Partial pressure] in Blood
0
11
0.00
0.21
0.0
2.5
—
8.1
—
0
11
(3012501) Base excess in Blood by calculation
0
11
0.00
0.21
0.0
2.5
—
3.4
—
0
5
(3013290) Carbon dioxide [Partial pressure] in Blood
0
11
0.00
0.21
0.0
2.5
—
5.0
—
0
11
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.9
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
0
11
0.00
0.21
0.0
1.6
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.3
—
1.3
—
0
10
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.8
—
105.5
—
0
10
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
1.8
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
0
10
0.00
0.21
0.0
2.6
—
17.8
—
0
5
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
0
10
0.00
0.21
0.0
2.1
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
0
12
0.00
0.21
0.0
2.8
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3008898) HLA-B27 [Presence]
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
0
13
0.00
0.21
0.0
1.6
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
15
173
0.81
0.21
3.1
3.0
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
16
138
1.23
0.21
4.1
2.5
u/l
36.9
55.0
2.48
16
133
(4034850)
0
14
0.00
0.20
0.0
22.6
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
17
148
1.22
0.20
2.4
2.3
nmol/l
78.7
76.2
0.09
17
130
(3044889) 12 lead EKG panel
33
314
1.14
0.11
3.5
4.1
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
17
156
1.13
0.09
1.8
1.9
pmol/l
93.1
84.1
—
7
73
(46235355) HIV 1 and 2 tests - Meaningful Use set
5
48
1.05
0.09
1.4
1.7
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
21
196
1.12
0.09
9.5
10.2
e9/l
0.0
0.0
0.47
16
161
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
5
61
0.80
0.09
5.4
10.2
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
14
152
0.89
0.07
3.3
2.8
e6/l
6.0
418.7
—
8
122
(3011397) Hemoglobin [Presence] in Urine by Test strip
11
100
1.13
0.06
2.3
4.3
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
14
131
1.09
0.04
2.1
2.2
u/l
93.4
328.8
1.05
14
124
(3002385) Erythrocyte distribution width [Ratio]
36
351
1.09
0.04
34.9
19.4
%
14.1
13.8
0.45
36
344
(36304419) Bacteria [Presence] in Urine
13
138
0.92
0.03
3.5
2.6
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
41
403
1.09
0.02
25.5
14.5
ml/min/173m2
89.0
78.7
3.50
34
334
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
21
216
0.95
0.00
2.6
2.4
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
14
141
0.99
0.00
3.3
2.6
e6/l
0.4
0.5
—
8
110
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(4094501)
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.3
—
0.3
—
0
9
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
13.8
—
0
5
(3002523) Influenza virus A Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(1616796) Gas panel - Central venous blood
0
9
0.00
0.00
0.0
4.1
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
2.6
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
0
8
0.00
0.00
0.0
2.0
—
61.9
—
0
8
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.9
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
0
8
0.00
0.00
0.0
2.6
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
2.6
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
0
5
0.00
0.00
0.0
1.0
—
88.9
—
0
5
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
0
5
0.00
0.00
0.0
1.4
—
34.2
—
0
5
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
0
5
0.00
0.00
0.0
3.4
—
0.9
—
0
5
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
0
8
0.00
0.00
0.0
2.4
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
75.2
—
0
6
(3003327) Ova and parasites identified in Stool by Light microscopy
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
3.7
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
5.3
—
16.6
—
0
7
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
0
8
0.00
0.00
0.0
1.8
—
4.9
—
0
8
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
2.6
—
—
—
0
0
(40768793) Breast Pathology biopsy report
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
0
7
0.00
0.00
0.0
2.6
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
8
85
0.93
0.00
4.6
6.8
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
2.4
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
2.4
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
2.6
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
0
7
0.00
0.00
0.0
2.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
2.4
—
—
—
0
0
(3029634) Reagin Ab [Titer] in Serum by VDRL
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
0
9
0.00
0.00
0.0
1.9
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(4062490)
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
0
6
0.00
0.00
0.0
4.0
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
0
9
0.00
0.00
0.0
3.6
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_OROPHARYNG – Malignant neoplasm of oropharyng
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).